Viewing Study NCT07010432


Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2026-01-28 @ 4:11 AM
Study NCT ID: NCT07010432
Status: RECRUITING
Last Update Posted: 2025-07-25
First Post: 2025-05-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Obesity View
Keywords: